Stallion India Fluorochemicals Limited
All news and filings related to Stallion India Fluorochemicals Limited.
View all news & filings- Medium impact
Stallion India Fluorochemicals Commences Commercial Operations at New Facility on Sep 21, 2026
Stallion India Fluorochemicals Limited will commence commercial operations at its new Semiconductor & Specialty Gas debulking and blending facility in Khalapur, Maharashtra on September 21, 2026. The facility has an installed capacity of 1,200 MT per annum and signifies the company's entry into the semiconductor and specialty gases market.
Read the summary - Low impact
Stallion India Fluorochemicals to Meet Canara HSBC Life Insurance on Sep 8, 2026
Stallion India Fluorochemicals Limited will meet with Canara HSBC Life Insurance on September 8, 2026. The virtual meeting is part of investor engagement, with no unpublished price-sensitive information to be discussed. The schedule is subject to change.
Read the summary - Low impact
Stallion India Fluorochemicals Limited Announces 24th AGM Details
Stallion India Fluorochemicals Limited has completed the dispatch of its 24th AGM notice and e-voting details. Advertisements were published in Free Press Journal and Navshakti on August 30, 2026. The company is following SEBI and Companies Act regulations.
Read the summary - Low impact
Stallion India Fluorochemicals to hold 24th AGM on Sept 21, 2026
Stallion India Fluorochemicals will hold its 24th AGM on September 21, 2026, via VC/OAVM. The cut-off date for e-voting eligibility is September 16, 2026. The agenda includes adopting FY26 financial statements and appointing/reappointing directors.
Read the summary - Low impact
Stallion India Fluorochemicals Limited Announces 24th AGM
Stallion India Fluorochemicals Limited will hold its 24th Annual General Meeting (AGM) via VC/ OAVM. A public notice regarding the AGM was published on August 28, 2026, in The Free Press Journal and Navshakti.
Read the summary - High impact
Stallion India Fluorochemicals Q1 FY27: Revenue up 12.78%, PAT grows 79.15%
Stallion India Fluorochemicals reported Q1 FY27 revenue of ₹124.68 crore (up 12.78% YoY) and PAT of ₹18.57 crore (up 79.15% YoY). Key projects include a high-purity helium plant commencing next quarter, Mambattu facility by year-end, and R32 plant by Dec 2026. The company maintains a 30-35% revenue CAGR guidance.
Read the summary - Low impact
Stallion India Fluorochemicals Reports Q1FY27 Monitoring Agency Report
Stallion India Fluorochemicals Limited's Monitoring Agency Report for Q1FY27 shows ₹192.91 crore utilized from its ₹363.93 crore Rights Issue as of June 30, 2026. Unutilized proceeds amount to ₹171.02 crore. No deviations from the Offer Document's objectives were noted. Land acquisition and manufacturing facility construction are progressing.
Read the summary - Low impact
Stallion India Fluorochemicals Releases Audio Recording of Q1 FY27 Earnings Conference Call
Stallion India Fluorochemicals has released the audio recording of its earnings conference call held on August 17th, 2026. The call discussed the unaudited financial results for the quarter ended June 30th, 2026. The recording is available on the company's investor relations website.
Read the summary - High impact
Stallion India Fluorochemicals Unveils Investor Presentation Highlighting Robust Growth and Strategic Expansion
Stallion India Fluorochemicals released an investor presentation outlining significant expansion plans. Key developments include the upcoming R-32 manufacturing facility at Bhilwara, with a ₹250 crore topline potential in FY26-27, and the commencement of operations at the Khalapur helium processing facility. The company projects a 30-35% CAGR for the next three years.
Read the summary - High impact
Stallion India Fluorochemicals Q1 FY27 PAT Surges 79% YoY to ₹18.57 Crore
Stallion India Fluorochemicals reported a strong Q1 FY27 with PAT surging 79% YoY to ₹18.57 crore. Revenue grew 12.78% to ₹124.68 crore, and EBITDA increased 75.85% to ₹25.27 crore. High-purity helium processing at Khalapur facility is complete, commercial operations expected next quarter. Mambattu facility to start by Nov-Dec 2026.
Read the summary - Low impact
Stallion India Fluorochemicals: Monitoring Agency Report for Q1FY27 Shows No Material Deviations
Stallion India Fluorochemicals' Monitoring Agency Report for Q1FY27 confirms no material deviations in IPO proceeds utilization. Previous deviations concerning issue expenses and land purchase for the Khalapur plant have been addressed via a June 3, 2026, Special Resolution. Unutilized proceeds of ₹5.00 crore are invested in FDs and an escrow account.
Read the summary - Medium impact
Stallion India Fluorochemicals Publishes Q1 FY27 Unaudited Financial Results
Stallion India Fluorochemicals reported Q1 FY27 results with Total Income at ₹32.59 lakh and Net Profit after tax at ₹7.37 lakh. This marks a turnaround from a net loss in the previous quarter. Basic and Diluted EPS was ₹0.13. The company also noted the impact of new Labour Codes.
Read the summary - Low impact
Stallion India Fluorochemicals Ltd. to hold Q1 FY27 Earnings Call on August 17, 2026
Stallion India Fluorochemicals Ltd. will host its Q1 FY27 earnings call on August 17, 2026, at 4:00 PM IST. The call will focus on the financial results for the quarter ended June 30, 2026. Mr. Shazad Rustomji, MD & CEO, will represent the management.
Read the summary - Medium impact
Stallion India Fluorochemicals Board Approves Q1 FY27 Results, Schedules AGM for Sep 21
Stallion India Fluorochemicals reported Q1 FY27 results with a profit before tax of ₹24.78 crore. The Board approved the financial results and took on record the Secretarial Audit Report. The company scheduled its Annual General Meeting (AGM) for September 21, 2026, and approved the book closure period from September 15 to September 21, 2026.
Read the summary - Low impact
Stallion India Fluorochemicals to meet Analysts/Investors on July 21, 2026
Stallion India Fluorochemicals Limited will hold meetings with analysts and investors on July 21, 2026. Ten firms, including Barclays Wealth and ICICI Securities, are scheduled to participate virtually. No unpublished price-sensitive information will be shared during these interactions.
Read the summary - Low impact
Stallion India Fluorochemicals: Certificate under SEBI Reg 74(5) for Q1 FY27
Stallion India Fluorochemicals Limited submitted a certificate for Q1 FY27 under SEBI (Depositories and Participants) Regulations, 2018. The Registrar confirmed the regulation is not applicable for member rematerialisation requests during the quarter ended June 30, 2026.
Read the summary - Low impact
Stallion India Fluorochemicals: Promoter Group Yearly Disclosure Under SEBI (SAST) Regulations
Stallion India Fluorochemicals Limited has filed its yearly disclosure for the financial year ended March 31, 2026. This submission is in accordance with SEBI (SAST) Regulations, 2011, and covers information from the promoter and promoter group.
Read the summary - Medium impact
Stallion India Fluorochemicals Shareholders Approve Variation in IPO Proceeds Object
Stallion India Fluorochemicals Limited's shareholders have passed a special resolution to approve variations in the objects of the IPO proceeds. The postal ballot results, confirmed by a scrutinizer's report on June 3, 2026, showed overwhelming support for the resolution, with over 99.98% of votes cast in favor.
Read the summary - Medium impact
Stallion India Fluorochemicals Releases Q4 & FY26 Earnings Call Transcript
Stallion India Fluorochemicals reported FY25-26 revenue of ₹434.12 crore (up 14.4% YoY), with PAT at ₹43.84 crore (up 35.61%). The company is on track for its R-32 plant in Bhilwara by October 2026 and expanding specialty gas facilities. Management targets 30-35% revenue CAGR over three years.
Read the summary - Medium impact
Stallion India Fluorochemicals: Monitoring Agency Report for Q4FY26 flags deviations
Stallion India Fluorochemicals Limited's Q4FY26 Monitoring Agency Report reveals deviations in IPO fund utilization. Excess spending of ₹3.99 crore on issue expenses and ₹3.71 crore on working capital is noted. Delays in capital expenditure projects for semiconductor and refrigerant facilities are also highlighted. Shareholder approval for deviations is pending.
Read the summary - Low impact
Stallion India Fluorochemicals: Audio Recording of Q4 FY26 Earnings Call Available
Stallion India Fluorochemicals Limited has released the audio recording of its earnings conference call held on May 18, 2026. The call discussed the audited financial results for the quarter and financial year ended March 31, 2026. The recording is accessible via a provided Google Drive link.
Read the summary - Low impact
Stallion India Fluorochemicals Publishes Audited Financial Results for FY26
Stallion India Fluorochemicals Limited has published its audited financial results for the fourth quarter and financial year ended March 31, 2026. The Board of Directors approved these results on May 13, 2026. The publication was made in accordance with SEBI regulations.
Read the summary - High impact
Stallion India Fluorochemicals Investor Presentation: Financial Results & Expansion Plans
Stallion India Fluorochemicals presented its Q4 FY26 results and expansion plans. Key highlights include a 10,000 MT R-32 manufacturing facility in Bhilwara, Rajasthan, with expected commissioning in October 2026 and a topline potential of ₹250 crore in FY26-27. The company is also expanding into high-purity helium and specialty gases, aiming for a 30-35% CAGR over the next three years.
Read the summary - High impact
Stallion India Fluorochemicals FY26 Revenue Up 14.4% to ₹434 Crore; PAT Jumps 35.6%
Stallion India Fluorochemicals reported FY26 Total Revenue of ₹434.12 crore, up 14.40% YoY. PAT increased 35.61% to ₹43.84 crore. The company expects its new R-32 manufacturing facility, commencing October 2026, to drive 30-35% revenue CAGR over three years.
Read the summary - Medium impact
Stallion India Fluorochemicals Appoints Ms. Swati Ghosh as Independent Director, Approves FY26 Audited Results
Stallion India Fluorochemicals approved its audited financial results for FY26. The Board appointed Ms. Swati Ghosh as an Independent Director for a five-year term. The company reported FY26 revenue from operations of ₹1,30,678 lakh and a profit after tax of ₹3,23,286 lakh. A Rights Issue raised approximately ₹363.93 crore.
Read the summary - Medium impact
Stallion India Fluorochemicals Schedules Q4 & FY26 Earnings Conference Call for May 18
Stallion India Fluorochemicals will host an earnings conference call on May 18, 2026, at 4:00 PM IST to discuss Q4 and FY 2025-26 financial results. The call will feature MD & CEO Shazad Rustomji. Registration is required.
Read the summary - Low impact
Stallion India Fluorochemicals: Newspaper Advertisement for Postal Ballot Notice
Stallion India Fluorochemicals Limited published newspaper advertisements confirming the dispatch of a postal ballot notice. This action is part of ongoing communication with stakeholders and regulatory bodies like NSE and BSE. The announcement also details various legal and debt recovery proceedings with significant financial implications and future hearing dates.
Read the summary - Medium impact
Stallion India Fluorochemicals seeks shareholder approval for IPO proceeds variation.
Stallion India Fluorochemicals is seeking shareholder approval to vary its IPO proceeds utilization. The company plans to acquire land for ₹7.80 Crore instead of constructing a warehouse, to enhance expansion capabilities. The remote e-voting period is from May 1, 2026, to May 30, 2026. Results are expected by June 6, 2026.
Read the summary - Low impact
Stallion India Clarifies Price Movement, Cites RIICO Plot, EC, and Sharjah Partnership
Stallion India Fluorochemicals Limited clarified its share price movement to NSE and BSE. The company highlighted prior disclosures including RIICO plot allotment, environmental clearance for an R-32 plant, land allotment, an MOU with the Rajasthan government, and a strategic partnership with Sharjah Oxygen Company for Liquid Helium sourcing. It confirmed no pending price-sensitive information.
Read the summary - Low impact
Gautam Lath Resigns as Independent Director of Stallion India Fluorochemicals
Gautam Lath has resigned as an Independent Director of Stallion India Fluorochemicals Limited, effective April 20th, 2026. The resignation is due to increasing professional commitments. He has stepped down from all board committees. The company has made the necessary regulatory filings.
Read the summary - Low impact
Stallion India Fluorochemicals Appoints Himani R. Patel & Associates as Internal Auditor for FY27
Stallion India Fluorochemicals Limited appointed M/s. Himani R. Patel & Associates as its Internal Auditor for FY 2026-27. The appointment was approved in a Board Meeting held on April 20, 2026. The firm is unrelated to the company's directors.
Read the summary - Medium impact
Stallion India Fluorochemicals: Board Approves Variation in IPO Proceeds Utilization
Stallion India Fluorochemicals' Board approved variations in IPO proceeds utilization. Mr. Gautam Lath resigned as Independent Director. Shareholders will vote via postal ballot, with April 24, 2026, set as the cut-off date for eligibility.
Read the summary - Low impact
Stallion India Fluorochemicals to Meet Analysts/Investors on April 23, 2026
Stallion India Fluorochemicals Limited will hold virtual meetings with analysts and investors on April 23, 2026. Participants include Philip PCG, Ashika Stock Broking, Ventura Securities, B&K Securities, Emkay Global, Spark Capital, and Sunidhi Securities. No unpublished price sensitive information will be shared.
Read the summary - Low impact
Stallion India Fluorochemicals Grants 15.8 Lakh ESOPs at ₹10 Exercise Price
Stallion India Fluorochemicals has granted 15,86,505 ESOPs under its 2025 plan. The exercise price is set at ₹10 per option. Vesting occurs over one year, and options are exercisable within four years post-vesting. This aligns with SEBI regulations for share-based benefits.
Read the summary - Low impact
Stallion India Fluorochemicals files SEBI Reg 74(5) certificate for Q4 FY26
Stallion India Fluorochemicals Limited submitted its quarterly certificate under SEBI (Depositories and Participants) Regulations, 2018 for the period ending March 31, 2026. The Registrar and Share Transfer Agent confirmed the regulation's non-applicability for rematerialisation requests during the quarter.
Read the summary - Low impact
Stallion India Fluorochemicals Closes Trading Window from April 1, 2026
Stallion India Fluorochemicals Limited has closed its trading window for designated persons from April 1, 2026. The window will reopen 48 hours after the declaration of audited financial results for the quarter and financial year ending March 31, 2026. The board meeting date for results declaration will be announced later.
Read the summary - Medium impact
Stallion India Fluorochemicals Approves Allotment of 3.67 Cr Equity Shares via Rights Issue
Stallion India Fluorochemicals approved the allotment of 3,67,60,483 equity shares via rights issue. The shares were issued at ₹99 each, including a ₹89 premium. The Board's Right Issue Committee approved this on March 02, 2026. Newspaper publication was on March 06, 2026.
Read the summary - Medium impact
Stallion India Allots 3.67 Crore Equity Shares at ₹99 per Share; Corrects Face Value to ₹10
Stallion India Fluorochemicals corrected its face value disclosure to ₹10 per share. On 2nd March 2026, the Rights Issue Committee approved the allotment of 3,67,60,483 equity shares at ₹99 each, in a 19:41 ratio, with a record date of 11th February 2026. Post-allotment, the paid-up equity share capital will be ₹1,16,08,57,370. Lapsed rights entitlements were extinguished.
Read the summary - Medium impact
Stallion India Fluorochemicals Approves Allotment of 3.67 Crore Shares via Rights Issue
Stallion India Fluorochemicals Limited's Rights Issue Committee approved the allotment of 3,67,60,483 equity shares at ₹99.00 per share. The issue was on a 19:41 rights basis, with a record date of 11th February, 2026. This allotment follows the Letter of Offer dated 12th February, 2026.
Read the summary - High impact
Stallion India Fluorochemicals Secures Land for HFO Plant in Rajasthan, Eyes ₹200 Crore Investment
Stallion India Fluorochemicals received land allotment approval from RIICO for a new HFO manufacturing plant in Rajasthan. The company plans an investment of approximately ₹200 crore, with work expected to start in 2027. This expansion aims to enhance their product portfolio and achieve a 30-35% revenue CAGR over three years.
Read the summary - Medium impact
Stallion India Fluorochemicals Announces Newspaper Advertisement for Rights Issue
Stallion India Fluorochemicals Limited has published a newspaper advertisement on February 17, 2026, announcing the opening of its Rights Issue of Equity shares. This action complies with SEBI regulations.
Read the summary - Medium impact
Stallion India Fluorochemicals: Monitoring Agency Report Flags Deviation in IPO Fund Utilization
Stallion India Fluorochemicals' Monitoring Agency Report for Q3FY26 reveals a ₹3.99 crore excess utilization in IPO issue expenses and a ₹3.71 crore excess for working capital. Delays are noted in CAPEX for semiconductor and refrigerant facilities. Management attributes deviations to unforeseen oversubscription costs and strategic fund reallocation.
Read the summary - High impact
Stallion India Fluorochemicals Approves Rights Issue Letter of Offer for ₹363.93 Crore
Stallion India Fluorochemicals Limited approved its Letter of Offer for a Rights Issue of 3,67,60,483 equity shares. The issue price is ₹99 per share, aggregating ₹363.93 Crore. The issue opens on February 20, 2026, and closes on February 27, 2026.
Read the summary - Medium impact
Stallion India Fluorochemicals Announces Rights Issue Schedule
Stallion India Fluorochemicals announced its Rights Issue schedule following a Board Meeting on February 12, 2026. The issue opens on February 20, 2026, and closes on February 27, 2026. The record date was February 11, 2026. Bigshare Services Private Limited is the Registrar to the Issue.
Read the summary - Medium impact
Stallion India Fluorochemicals' R-32 Plant in Rajasthan to Benefit from RIPS 2024 Subsidies
Stallion India Fluorochemicals' new R-32 manufacturing plant in Rajasthan will benefit from the Rajasthan Investment Promotion Scheme (RIPS) 2024. The project qualifies for significant incentives including capital subsidies, SGST exemptions, and interest subvention, enhancing project viability and returns. SIFL aims to achieve a 30-35% revenue CAGR.
Read the summary - High impact
Stallion India Fluorochemicals Signs MoU with Rajasthan Govt for ₹200 Cr HFO Plant
Stallion India Fluorochemicals Limited signed an MoU with the Government of Rajasthan to set up an HFO manufacturing plant in Bhilwara. The company proposes an investment of ₹200 crore for the facility, with work beginning in 2027. Management is confident in achieving a 30-35% revenue CAGR over the next three years.
Read the summary - High impact
Stallion India Fluorochemicals Q3 FY26 Concall Transcript Released
Stallion India Fluorochemicals reported Q3 FY26 revenue of ₹104.87 Cr (up 23.2% YoY) and 9M FY26 revenue of ₹321.18 Cr (up 41.7% YoY). The company received environmental clearance for its 10,000 MT R-32 plant in Bhilwara, targeting August 2026 commissioning. A rights issue aims to raise ₹364 Cr for capacity expansion. FY26 revenue guidance remains ₹430 Cr.
Read the summary - Medium impact
Stallion India Fluorochemicals Sets Feb 11, 2026 as Record Date for Rights Issue
Stallion India Fluorochemicals Limited has set February 11, 2026, as the record date for its upcoming rights issue. Shareholders will be eligible to receive 19 equity shares for every 41 shares held.
Read the summary - Medium impact
Stallion India Fluorochemicals Approves Rights Issue of ₹363.93 Crore
Stallion India Fluorochemicals approved a Rights Issue of 3,67,60,483 equity shares at ₹99 each, aiming to raise ₹363.93 Crore. Eligible shareholders will receive 19 shares for every 41 held. The Record Date is February 11, 2026.
Read the summary - Low impact
Stallion India Fluorochemicals Ltd. Corrects Earnings Conference Call Audio Link
Stallion India Fluorochemicals Limited has issued a correction for the earnings conference call audio recording link. The call, held on February 3, 2026, discussed results for the quarter and nine months ended December 31, 2025. The company apologized for the error and provided the correct link.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio